Skip to content

Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures

Prospective, Randomized and Double Blind Study of Parallels Groups for Evaluating the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures in Three or Four Fragments

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02075476
Enrollment
40
Registered
2014-03-03
Start date
2013-05-31
Completion date
2016-08-06
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A02.835.232.087.090.400.400

Keywords

Fracture-luxation, humeral proximal extremity, Hemiarthroplasty, reverse Arthroplasty

Brief summary

The purpose of this study is to evaluate the effectiveness and safety of two surgical techniques for the treatments of proximal extremity humeral fractures and fractures luxation in three o four fragments of Neer's classification.

Detailed description

Proximal extremity humeral fractures present high prevalence. It's estimated about 10% of all fractures. Their incidence is 6,6/1000 people-year and this amount increases from 40 years old. The majority are successfully treated with immobilization and rehabilitation. The surgical treatment is recommended in case of displacement. In elderly population with fractures types three or four of Neer's classification there is no consensus on which technique is the best surgical option. Classically hemiarthroplasty has been widely performed as a reconstruction method but its outcomes in old patients are unclear due to the bad bone quality and joint features. Recently some authors recommend the reverse arthroplasty in patients over 70 years old . The aim of this study is to compare the results between Hemiarthroplasty and reverse arthroplasty in patients over 70 years old. As far as the investigators are concerned there's no published studies like this.

Interventions

PROCEDUREHemiarthroplasty
PROCEDUREreverse arthroplasty

Sponsors

Carlos Alvarez
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with humeral proximal extremity fracture or fracture luxation in three or four fragments of Neer's classification. * Patient 70 years older * Signed informed consent.

Exclusion criteria

* Any condition to make worse the functional recovery or avoid the patient collaboration with the rehabilitation program ( cognitive disability, neurological pathology…) * Glenohumeral osteoarthritis * Inflammatory arthropathies * Previous cuff arthropatyy * High surgical or anesthesia risk * Any disease or condition that the investigator finds decisive for exclusion.

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score36 monthschanges en ASES (AMERICAN SHOULDER AND ELBOW) score will be measured. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. This questionary includes a section on pain (7 items) and a section on activities of daily living (10 items). Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition.
Effectiveness Will be Measured for Constant Score36 monthschanges in Constant score will be measured. The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.
Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score36 monthschanges in DASH (Disabilities of the Arm, Shoulder and Hand) score will be measured. The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is a 30-item, self-report questionnaire designed to assess the patient's health status during the previous week. The items enquire about the degree of difficulty in performing different physical activities because of arm, shoulder and hand problems (21 items), the severity of each of the symptoms of pain, activity-related pain, tingling, weakness and stiffness (five items) and the impact of the problem on social functioning, work, sleep and self-image (four items). Each item has five response options. The scores are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)

Countries

Spain

Participant flow

Participants by arm

ArmCount
Hemiarthroplasty Global Fx(DePuy)
in this technique the prosthesis is implanted in similar approach to shoulder anatomy Hemiarthroplasty
20
Reverse Arthroplasty Delta Xtent(DePuy)
In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy reverse arthroplasty
19
Total39

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath22
Overall StudyLost to Follow-up13

Baseline characteristics

CharacteristicReverse Arthroplasty Delta Xtent(DePuy)TotalHemiarthroplasty Global Fx(DePuy)
Age, Continuous77 years76 years76 years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Spain
19 participants39 participants20 participants
Sex: Female, Male
Female
13 Participants27 Participants14 Participants
Sex: Female, Male
Male
6 Participants12 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 20
other
Total, other adverse events
0 / 190 / 20
serious
Total, serious adverse events
0 / 190 / 20

Outcome results

Primary

Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score

changes en ASES (AMERICAN SHOULDER AND ELBOW) score will be measured. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. This questionary includes a section on pain (7 items) and a section on activities of daily living (10 items). Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition.

Time frame: 36 months

ArmMeasureValue (MEAN)
Hemiarthroplasty Global Fx(DePuy)Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score66 score on a scale
Reverse Arthroplasty Delta Xtent(DePuy)Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score77 score on a scale
p-value: 0.048Mixed Models Analysis
Primary

Effectiveness Will be Measured for Constant Score

changes in Constant score will be measured. The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.

Time frame: 36 months

ArmMeasureValue (MEAN)
Hemiarthroplasty Global Fx(DePuy)Effectiveness Will be Measured for Constant Score53 score on a scale
Reverse Arthroplasty Delta Xtent(DePuy)Effectiveness Will be Measured for Constant Score70 score on a scale
p-value: 0.001Mixed Models Analysis
Primary

Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score

changes in DASH (Disabilities of the Arm, Shoulder and Hand) score will be measured. The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is a 30-item, self-report questionnaire designed to assess the patient's health status during the previous week. The items enquire about the degree of difficulty in performing different physical activities because of arm, shoulder and hand problems (21 items), the severity of each of the symptoms of pain, activity-related pain, tingling, weakness and stiffness (five items) and the impact of the problem on social functioning, work, sleep and self-image (four items). Each item has five response options. The scores are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)

Time frame: 36 months

ArmMeasureValue (MEAN)
Hemiarthroplasty Global Fx(DePuy)Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score26 score on a scale
Reverse Arthroplasty Delta Xtent(DePuy)Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score13 score on a scale
p-value: 0.011Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026